BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10200158)

  • 1. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the Escherichia coli peptide deformylase.
    Chan MK; Gong W; Rajagopalan PT; Hao B; Tsai CM; Pei D
    Biochemistry; 1997 Nov; 36(45):13904-9. PubMed ID: 9374869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion.
    Meinnel T; Lazennec C; Villoing S; Blanquet S
    J Mol Biol; 1997 Apr; 267(3):749-61. PubMed ID: 9126850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of substrate analogue inhibitors of peptide deformylase.
    Meinnel T; Patiny L; Ragusa S; Blanquet S
    Biochemistry; 1999 Apr; 38(14):4287-95. PubMed ID: 10194346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
    Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
    J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase.
    Meinnel T; Blanquet S; Dardel F
    J Mol Biol; 1996 Sep; 262(3):375-86. PubMed ID: 8845003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification, characterization, and inhibition of peptide deformylase from Escherichia coli.
    Rajagopalan PT; Datta A; Pei D
    Biochemistry; 1997 Nov; 36(45):13910-8. PubMed ID: 9374870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of substrate specificity for peptide deformylase through the screening of a combinatorial peptide library.
    Hu YJ; Wei Y; Zhou Y; Rajagopalan PT; Pei D
    Biochemistry; 1999 Jan; 38(2):643-50. PubMed ID: 9888804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron center, substrate recognition and mechanism of peptide deformylase.
    Becker A; Schlichting I; Kabsch W; Groche D; Schultz S; Wagner AF
    Nat Struct Biol; 1998 Dec; 5(12):1053-8. PubMed ID: 9846875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of peptide deformylase inhibitors.
    Huntington KM; Yi T; Wei Y; Pei D
    Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bacterial peptide deformylase by biaryl acid analogs.
    Green BG; Toney JH; Kozarich JW; Grant SK
    Arch Biochem Biophys; 2000 Mar; 375(2):355-8. PubMed ID: 10700392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
    Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
    Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of nickel-peptide deformylase.
    Dardel F; Ragusa S; Lazennec C; Blanquet S; Meinnel T
    J Mol Biol; 1998 Jul; 280(3):501-13. PubMed ID: 9665852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
    Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
    Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum.
    Bracchi-Ricard V; Nguyen KT; Zhou Y; Rajagopalan PT; Chakrabarti D; Pei D
    Arch Biochem Biophys; 2001 Dec; 396(2):162-70. PubMed ID: 11747293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the active site zinc ligands of peptide deformylase.
    Meinnel T; Lazennec C; Blanquet S
    J Mol Biol; 1995 Nov; 254(2):175-83. PubMed ID: 7490741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
    Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
    In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.